To derive further novel and functionally relevant putative MYCN co-dependencies during neuroblastoma tumor progression, we also integrated the time-resolved transcriptome dataset with common hits of CRISPR based screening data in MYCN-amplified and neuroblastoma cells [28,61] and with neuroblastoma specific hits as defined by the pediatric cancer dependency map initiative [68]. The gene discussed is MYCN; the disease is neuroblastoma.